-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Eledon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.5M, a 40.1% decline year-over-year.
- Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$46.9M, a 48.3% increase year-over-year.
- Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$43M, a 51.4% increase from 2022.
- Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$88.4M, a 140% decline from 2021.
- Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$36.9M, a 99.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)